Polar Capital Holdings Plc Q1 2021 Filing

Filed May 17, 2021

Portfolio Value

$16.2B

Holdings

319

Report Date

Q1 2021

Filing Type

13F-HR

All Holdings (319 positions)

#StockSharesValue% PortfolioType
301
ICUIICU MED INC
2,223$457.0M2.83%
302
OCULOCULAR THERAPEUTIX INC
27,539$452.0M2.80%
303
CHECHEMED CORP NEW
927$426.0M2.64%
304
PGNYPROGYNY INC
9,223$411.0M2.54%
305
ESTAESTABLISHMENT LABS HLDGS INC
6,367$398.0M2.46%
306
HQYHEALTHEQUITY INC
5,681$386.0M2.39%
307
HDBHDFC BANK LTD
4,933$383.0M2.37%
308
SPNEUSDSEASPINE HLDGS CORP
19,901$346.0M2.14%
309
ONCOCYTE CORP
66,529$345.0M2.14%
310
ASNDASCENDIS PHARMA A/S
2,524$325.0M2.01%
311
DVAXDYNAVAX TECHNOLOGIES CORP
30,468$300.0M1.86%
312
INTERSECT ENT INC
12,856$268.0M1.66%
313
CBAYUSDCYMABAY THERAPEUTICS INC
56,630$257.0M1.59%
314
SILKSILK RD MED INC
4,854$246.0M1.52%
315
YMABUSDY-MABS THERAPEUTICS INC
8,029$243.0M1.50%
316
IRTCIRHYTHM TECHNOLOGIES INC
1,615$224.0M1.39%
317
TREVENA INC
106,900$191.0M1.18%
318
IQIYI INC
100,000$101.0M0.63%
319
PHOENIX NEW MEDIA LTD
54,784$97.0M0.60%
PreviousPage 4 of 4